These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Integrative genomics--a basic and essential tool for the development of molecular medicine. Ostrowski J Acta Pol Pharm; 2008; 65(6):621-4. PubMed ID: 19172842 [TBL] [Abstract][Full Text] [Related]
4. Genomics and proteomics: emerging technologies in clinical cancer research. Chung CH; Levy S; Chaurand P; Carbone DP Crit Rev Oncol Hematol; 2007 Jan; 61(1):1-25. PubMed ID: 17015021 [TBL] [Abstract][Full Text] [Related]
5. Integrating genomics, proteomics and bioinformatics in translational studies of molecular medicine. Ostrowski J; Wyrwicz LS Expert Rev Mol Diagn; 2009 Sep; 9(6):623-30. PubMed ID: 19732006 [TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
7. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers. Lee JW; Figeys D; Vasilescu J Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683 [TBL] [Abstract][Full Text] [Related]
8. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics. Phan JH; Quo CF; Wang MD Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers: a valuable tool in clinical research and medical practice. Carini C IDrugs; 2007 Jun; 10(6):395-8. PubMed ID: 17642003 [TBL] [Abstract][Full Text] [Related]
10. Prospects for personalized cardiovascular medicine: the impact of genomics. Ginsburg GS; Donahue MP; Newby LK J Am Coll Cardiol; 2005 Nov; 46(9):1615-27. PubMed ID: 16256859 [TBL] [Abstract][Full Text] [Related]
11. Genomic medicine and thrombotic risk: who, when, how and why? Federici C; Gianetti J; Andreassi MG Int J Cardiol; 2006 Jan; 106(1):3-9. PubMed ID: 16102857 [TBL] [Abstract][Full Text] [Related]
12. Primer: genomic and proteomic tools for the molecular dissection of disease. Walker EJ; Siminovitch KA Nat Clin Pract Rheumatol; 2007 Oct; 3(10):580-9. PubMed ID: 17906613 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics in clinical practice: considerations for testing. Constable S; Johnson MR; Pirmohamed M Expert Rev Mol Diagn; 2006 Mar; 6(2):193-205. PubMed ID: 16512779 [TBL] [Abstract][Full Text] [Related]
14. Genomic and genetic biomarkers of toxicity. Mendrick DL Toxicology; 2008 Mar; 245(3):175-81. PubMed ID: 18206287 [TBL] [Abstract][Full Text] [Related]
15. Risk assessment and pharmacogenetics in molecular and genomic epidemiology. Park SK; Choi JY J Prev Med Public Health; 2009 Nov; 42(6):371-6. PubMed ID: 20009483 [TBL] [Abstract][Full Text] [Related]
16. The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice. Ross JS; Ginsburg GS Am J Clin Pathol; 2003 Jan; 119(1):26-36. PubMed ID: 12520694 [TBL] [Abstract][Full Text] [Related]
17. Overview of personalized medicine in the disease genomic era. Hong KW; Oh B BMB Rep; 2010 Oct; 43(10):643-8. PubMed ID: 21034525 [TBL] [Abstract][Full Text] [Related]
18. The genome-enabled electronic medical record. Hoffman MA J Biomed Inform; 2007 Feb; 40(1):44-6. PubMed ID: 16616698 [TBL] [Abstract][Full Text] [Related]